Back
Innate Pharma SA Stock Price Chart
Sponsored
IPHA
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
29
IPHA
Innate Pharma SA
Last Price:
1.67
Seasonality Move:
8.67%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPHA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Innate Pharma SA Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.65 | Buy |
20-day SMA: | 1.77 | Sell |
50-day SMA: | 1.99 | Sell |
200-day SMA: | 2.31 | Sell |
8-day EMA: | 1.64 | Buy |
20-day EMA: | 1.76 | Sell |
50-day EMA: | 1.93 | Sell |
200-day EMA: | 2.25 | Sell |
Innate Pharma SA Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.12 | Sell |
Relative Strength Index (14 RSI): | 44.79 | Sell |
Chaikin Money Flow: | 4532 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.65 - 1.97) | Sell |
Bollinger Bands (100): | (1.9 - 2.3) | Sell |
Innate Pharma SA Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Innate Pharma SA Stock
Is Innate Pharma SA Stock a Buy?
- Innate Pharma SA share price is 1.69 while IPHA 8-day simple moving average is 1.65, which is a Buy signal.
- The stock price of IPHA is 1.69 while Innate Pharma SA 20-day SMA is 1.77, which makes it a Sell.
- Innate Pharma SA 50-day simple moving average is 1.99 while IPHA share price is 1.69, making it a Sell technically.
- IPHA stock price is 1.69 and Innate Pharma SA 200-day simple moving average is 2.31, creating a Sell signal.
IPHA Technical Analysis vs Fundamental Analysis
Sell
29
Innate Pharma SA (IPHA)
is a Sell
Is Innate Pharma SA a Buy or a Sell?
-
Innate Pharma SA stock is rated a Sell
The current Innate Pharma SA [IPHA] share price is $1.69. The Score for IPHA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
Innate Pharma SA Stock Info
Market Cap:
136.44M
Price in USD:
1.69
Share Volume:
6.38K
Innate Pharma SA 52-Week Range
52-Week High:
3.15
52-Week Low:
1.29
Sell
29
Innate Pharma SA (IPHA)
is a Sell
Innate Pharma SA Share Price Forecast
-
What is the Innate Pharma SA stock price today?
The Innate Pharma SA stock price is 1.69 USD today. -
Will IPHA stock go up or go down?
Innate Pharma SA> share price is forecast to RISE/FALL based on technical indicators -
Is Innate Pharma SA overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Innate Pharma SA is overvalued.
Is Innate Pharma SA Stock a Buy?
- Innate Pharma SA share price is 1.69 while IPHA 8-day exponential moving average is 1.64, which is a Buy signal.
- The stock price of IPHA is 1.69 while Innate Pharma SA 20-day EMA is 1.76, which makes it a Sell.
- Innate Pharma SA 50-day exponential moving average is 1.93 while IPHA share price is 1.69, making it a Sell technically.
- IPHA stock price is 1.69 and Innate Pharma SA 200-day simple moving average is 2.25, creating a Sell signal.
Fundamental Analysis of Innate Pharma SA
Is Innate Pharma SA a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Innate Pharma SA
Should I short Innate Pharma SA stock?
- IPHA Moving Average Covergence Divergence (MACD) indicator is -0.12, suggesting Innate Pharma SA is a Sell
- Innate Pharma SA Relative Strength Index (RSI) is 44.79, which suggest Innate Pharma SA is oversold
- The Bollinger Bands (25) for Innate Pharma SA is (1.65 - 1.97), which suggest Innate Pharma SA is a Sell
- The Bollinger Bands (100) for Innate Pharma SA is (1.9 - 2.3), which suggest Innate Pharma SA is a Sell
* Innate Pharma SA stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.